Ochronosis

Ochronosis is a condition that causes skin and connective tissues to turn a dark, rusty-brown color. It happens because a substance called homogentisic acid builds up in the body. This buildup is linked to a rare genetic disorder called alkaptonuria, where the body can't properly break down certain amino acids. The brown color is like rust, hence the name 'ochronosis'.

Condition

What people with Ochronosis report

Every report comes from a Lived member, sent anonymously.

Have you had Joint Replacement for Ochronosis?

NameHow it went

About Ochronosis

What It Is

Ochronosis is a dark, bluish-black or gray-blue discoloration caused by pigment building up in the body's connective tissues, such as cartilage, tendons and skin. It happens in two quite different situations, and which one a person has shapes almost everything about what it means. The inherited form is part of alkaptonuria, a rare genetic disease in which the body cannot fully break down a substance called homogentisic acid. The acid collects in tissues throughout the body and slowly turns them dark and stiff. Urine that turns dark or black when it stands is often the first sign. Visible pigment in the whites of the eyes, the ear cartilage and the skin of the hands usually appears after age 30, and arthritis of the spine, hips and knees often starts in early adulthood. Over time the deposits can also affect heart valves, the kidneys and the prostate. The acquired form, called exogenous ochronosis, is limited to the skin. It usually appears as lacy, blue-black or gray-blue patches on the face after long-term use of skin-lightening creams, most often those containing hydroquinone. Because it can look like melasma (common brown facial patches), it is easy to miss.

Causes & Risk Factors

Alkaptonuria is caused by changes in the HGD gene, which carries instructions for an enzyme that breaks down two protein building blocks, phenylalanine and tyrosine. It is inherited in an autosomal recessive pattern: a person has the disease only if they inherit a nonworking copy of the gene from each parent. Parents who carry one copy usually have no symptoms. When both parents are carriers, each child has a one in four chance of having alkaptonuria. The disease is rare in the United States, affecting roughly 1 in 250,000 to 1 in 1 million people, and is more common in parts of Slovakia and the Dominican Republic. Exogenous ochronosis is caused by what goes on the skin, not by genes. It has mostly been reported in people with darker skin who used hydroquinone creams for years, particularly products stronger than 4%, but cases have also followed shorter use and lower strengths. Skin-lightening products of unknown content are a common source. Other chemicals, including phenol, have also been linked to ochronosis.

How It's Diagnosed

For alkaptonuria, the key test is a urine test that measures homogentisic acid. People with the disease pass large amounts each day, while healthy people pass almost none. Genetic testing for changes in both copies of the HGD gene confirms the diagnosis and makes it possible to test relatives. Because brothers and sisters can be affected without symptoms yet, they may be offered testing too. Once the diagnosis is made, imaging of the spine and joints and a heart ultrasound help show how far the disease has progressed. Exogenous ochronosis is suspected when facial pigmentation darkens, rather than fades, during use of a lightening cream. A dermatologist looks closely at the skin, often with a dermatoscope (a lighted magnifier), and asks about every product used, including creams bought abroad or without a label. A small skin biopsy can confirm it by showing the characteristic yellow-brown, banana-shaped pigment fibers in the deeper skin layer.

Treatment Options

For alkaptonuria, the main options are a medicine that lowers homogentisic acid and care for the joints, heart and kidneys. Nitisinone (Harliku) is a once-daily tablet approved in the United States in 2025 for adults with alkaptonuria. It blocks an earlier step in tyrosine breakdown, so far less homogentisic acid is made. In a four-year trial, it cut the acid in urine by more than 99% and slowed the buildup of pigment and the progression of symptoms. It does not undo damage that has already happened. Because nitisinone raises blood tyrosine, it can irritate the eyes and, less often, cause painful thickened skin on the palms and soles. People taking it have an eye exam before starting and regularly afterward, along with blood counts, and some need a diet lower in protein if tyrosine climbs too high. Joint care is the other pillar. Pain relief, physical therapy and occupational therapy help keep strength and movement. Avoiding heavy manual labor and high-impact sports may reduce wear on the spine and large joints. Many people eventually need knee, hip or shoulder replacement. Kidney or prostate stones, narrowed heart valves and an underactive thyroid are treated as they would be in anyone else, including valve replacement when needed. For exogenous ochronosis, the essential step is stopping hydroquinone and any other lightening product, since continuing it makes the pigment worse. Strict daily sun protection helps keep it from darkening further. A dermatologist may try retinoid creams, chemical peels or lasers, but results vary and treatment is often only partly successful.

What to Expect

Alkaptonuria is lifelong and slowly progressive, though the pace differs from person to person. Back stiffness and joint pain tend to build through the 30s and 40s, and limited movement of the spine and large joints is a major part of daily life for many people. With appropriate care, life expectancy is generally normal. Regular follow-up is aimed at catching problems early: after age 40, a regular heart ultrasound (echocardiogram) checks the heart valves and the main artery, and thyroid tests are repeated every one to two years. For people taking nitisinone, the eye exams and blood tests become part of the routine. Exogenous ochronosis is a skin condition and does not affect other organs. Once the cause is stopped, pigmentation usually stops getting worse, but it fades slowly and may never clear completely. That can be hard to accept, especially when the cream was started to treat discoloration in the first place.

When to Seek Help

See a clinician if urine regularly turns dark or black on standing, or if a family member has alkaptonuria and you have not been tested. See a dermatologist if facial patches turn darker, gray or blue-black while you are using a skin-lightening cream, and bring the product with you. If you have alkaptonuria, raise new or worsening back or joint pain, shortness of breath or chest discomfort on exertion, or symptoms of kidney stones at your next visit or sooner if they are severe. If you take nitisinone, contact your care team promptly about eye pain, sensitivity to light, or red, swollen or burning eyes.

Questions to Ask Your Doctor

  1. 1.Is this ochronosis from alkaptonuria or from something I have put on my skin, and how can we tell for certain?
  2. 2.Would nitisinone make sense for me now, and what monitoring would it involve?
  3. 3.Which tests of my heart, kidneys and joints should I have, and how often?
  4. 4.What kinds of work, exercise and activities are best for protecting my spine and joints?
  5. 5.Should my brothers, sisters or children be tested, and would genetic counseling help us?

Last reviewed • Oct 2026

Educational content, not medical advice.